Wealth Architects LLC Boosts Holdings in The Procter & Gamble Company (NYSE:PG)

Posted by Defense World Staff on Jul 9th, 2023

Wealth Architects LLC lifted its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 2.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,952 shares of the company’s stock after purchasing an additional 191 shares during the period. Wealth Architects LLC’s holdings in Procter & Gamble were worth $1,182,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of PG. EWG Elevate Inc. bought a new position in shares of Procter & Gamble in the 4th quarter worth about $26,000. Silicon Valley Capital Partners bought a new position in shares of Procter & Gamble in the 4th quarter worth about $28,000. Legend Financial Advisors Inc. bought a new position in shares of Procter & Gamble in the 3rd quarter worth about $30,000. Luken Investment Analytics LLC bought a new position in shares of Procter & Gamble in the 4th quarter worth about $37,000. Finally, Bourgeon Capital Management LLC increased its stake in Procter & Gamble by 39.9% during the 4th quarter. Bourgeon Capital Management LLC now owns 249 shares of the company’s stock valued at $38,000 after purchasing an additional 71 shares in the last quarter. 64.65% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $148.80 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.59 and a quick ratio of 0.39. The Procter & Gamble Company has a 1-year low of $122.18 and a 1-year high of $158.11. The company has a market capitalization of $350.72 billion, a P/E ratio of 25.92, a P/E/G ratio of 3.83 and a beta of 0.42. The firm’s 50 day simple moving average is $149.97 and its two-hundred day simple moving average is $147.38.

Procter & Gamble (NYSE:PG – Free Report) last released its earnings results on Friday, April 21st. The company reported $1.37 EPS for the quarter, topping the consensus estimate of $1.32 by $0.05. Procter & Gamble had a net margin of 17.69% and a return on equity of 32.18%. The firm had revenue of $20.07 billion for the quarter, compared to the consensus estimate of $19.32 billion. During the same quarter in the previous year, the firm earned $1.33 earnings per share. The company’s quarterly revenue was up 3.5% compared to the same quarter last year. Research analysts expect that The Procter & Gamble Company will post 5.86 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, May 15th. Stockholders of record on Friday, April 21st were issued a $0.9407 dividend. This represents a $3.76 annualized dividend and a dividend yield of 2.53%. The ex-dividend date was Thursday, April 20th. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.91. Procter & Gamble’s payout ratio is 65.51%.

Insider Transactions at Procter & Gamble

In related news, CEO Ma. Fatima Francisco sold 8,000 shares of the business’s stock in a transaction on Monday, April 24th. The shares were sold at an average price of $156.84, for a total value of $1,254,720.00. Following the sale, the chief executive officer now owns 9,343 shares in the company, valued at $1,465,356.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, CFO Andre Schulten sold 25,244 shares of the business’s stock in a transaction on Monday, April 24th. The shares were sold at an average price of $155.27, for a total value of $3,919,635.88. Following the sale, the chief financial officer now owns 27,118 shares in the company, valued at $4,210,611.86. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Ma. Fatima Francisco sold 8,000 shares of the business’s stock in a transaction on Monday, April 24th. The shares were sold at an average price of $156.84, for a total transaction of $1,254,720.00. Following the transaction, the chief executive officer now owns 9,343 shares in the company, valued at approximately $1,465,356.12. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 95,093 shares of company stock valued at $14,821,930. 0.26% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on PG shares. UBS Group raised their price objective on shares of Procter & Gamble from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Monday, April 24th. Barclays raised their price objective on shares of Procter & Gamble from $160.00 to $167.00 in a research note on Wednesday, April 26th. Truist Financial lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and reduced their price target for the stock from $165.00 to $155.00 in a research note on Thursday, May 18th. Royal Bank of Canada lifted their price target on shares of Procter & Gamble from $160.00 to $165.00 and gave the stock a “sector perform” rating in a research note on Monday, April 24th. Finally, Morgan Stanley lifted their price target on shares of Procter & Gamble from $160.00 to $174.00 and gave the stock an “overweight” rating in a research note on Monday, April 24th. Five equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $161.50.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.